Quick-Med Technologies, Inc.

Equities

QMDT

US74837Q1067

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 12:10:26 2024-04-19 pm EDT			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		0.00%	-50.00%

2014	Quick-Med Technologies Inc. Signs License with Medline Industries, Inc. to Provide Stay-Fresh(R) Antimicrobial Technology for Traditional Wound Care Products	CI
2014	Quick-Med Technologies, Inc. Licenses its Stay Fresh Technology to Sarasota Medical Products for Use in Ostomy and Wound Care Products	CI

Quick-Med Technologies Inc. Auditor Raises 'Going Concern' Doubt

September 30, 2013 at 07:04 am EDT

Quick-Med Technologies Inc. filed its 10-K on Sep 30, 2013 for the period ending Jun 30, 2013. In this report its auditor, Daszkal Bolton LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about Quick-Med Technologies, Inc.

Quick-Med Technologies Inc. Signs License with Medline Industries, Inc. to Provide Stay-Fresh(R) Antimicrobial Technology for Traditional Wound Care Products	14-02-28	CI
Quick-Med Technologies, Inc. Licenses its Stay Fresh Technology to Sarasota Medical Products for Use in Ostomy and Wound Care Products	14-01-14	CI
Quick-Med Technologies Inc. Auditor Raises 'Going Concern' Doubt	13-09-30	CI
Quick-Med Technologies Inc. Signs License with Polartec, LLC	13-08-27	CI
FDA Clears Quick-Med Technologies Inc.'s Stay-Fresh(R) Medical Textile Product	13-05-29	CI
Quick-Med Technologies Wins Contract to Develop Wound Healing Technology to Control Scar Contracture in Burn Patients	13-05-22	CI
Quick-Med Technologies Inc. Announces Expanded Global Distribution of Advanced Dressings with NIMBUS (R) Technology	13-05-14	CI
Quick-Med Technologies Inc. Announces Board Appointments	13-02-28	CI
Quick-Med Technologies Inc. Announces Resignation of Ladd Greeno as Member and Chairman of the Board of Directors	13-02-01	CI
Quick-Med Technologies Inc. Announces Executive Changes	13-01-15	CI
Quick-Med Technologies Inc. Announces Update on Appointment of John W. Sheets as Director	13-01-14	CI
Quick-Med Announces Commercial Sale of Advanced Dressings with NIMBUS(R) Technology	13-01-08	CI
Quick-Med Technologies Inc. Appoints John W. Sheets, Jr. as Board of Director	12-11-14	CI
Quick-Med Technologies Inc. Announces Resignation of George Friel as a Member of Board of Directors	12-11-13	CI
Quick-Med Technologies Inc. Auditor Raises 'Going Concern' Doubt	12-09-28	CI
Quick-Med Technologies to Receive US Patent on Novel Antimicrobial Technology Based on Hydrogen Peroxide	12-09-12	CI
Quick-Med Technologies Inc. Announces Expanded Regulatory Clearance for Stay Fresh(R) Antimicrobial	12-08-07	CI
Quick-Med Technologies Inc. Announces Management Changes	12-07-31	CI
Derma Sciences Inc. Enters Patent and Technology License Agreement with Quick-Med Technologies Inc	12-07-18	CI
Derma Sciences Acquires Global Long-Term Exclusive Rights to Nimbus Technology from Quick-Med Technologies Inc	12-07-13	CI
Quick-Med Technologies Signs Patent and Technology License Agreement with Doris Hosiery Mills, Limited	12-05-07	CI
Quick-Med Technologies Inc. Expands NIMBUS(R) Technology into Advanced Wound Care Dressings	12-02-14	CI

Chart Quick-Med Technologies, Inc.

Duration

Period

More charts

Company Profile

Quick-Med Technologies, Inc. is a life sciences company. The Company is focused on developing technologies for infection prevention and control in the consumer and healthcare markets. The Company offers four technologies, including NIMBUS, Stay Fresh, NimbuDerm and MultiStat. NIMBUS is a family of advanced polymers bioengineered for antimicrobial, hemostatic, and other properties that can be used in a range of medical device applications, including wound dressings, medical textiles, catheters, tubing, films and coatings. Stay Fresh is a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria even after numerous laundering cycles. NimbuDerm is a copolymer for application as a persistent hand sanitizer with long lasting protection against germs. MultiStat is a family of patented methods and compounds shown to be effective in skin therapy applications.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
QUICK-MED TECHNOLOGIES, INC.	-50.00%	3.73K
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research